Hildenbrand R - Search Results

1

Urokinase-type plasminogen activator induces proliferation in breast cancer cells.

Gandhari M, Arens N, Majety M, Dorn-Beineke A, Hildenbrand R. Gandhari M, et al. Among authors: hildenbrand r. Int J Oncol. 2006 Jun;28(6):1463-70. Int J Oncol. 2006. PMID: 16685447

2

The urokinase-system--role of cell proliferation and apoptosis.

Hildenbrand R, Gandhari M, Stroebel P, Marx A, Allgayer H, Arens N. Hildenbrand R, et al. Histol Histopathol. 2008 Feb;23(2):227-36. doi: 10.14670/HH-23.227. Histol Histopathol. 2008. PMID: 17999379 Review.

3

In vitro suppression of urokinase plasminogen activator in breast cancer cells--a comparison of two antisense strategies.

Arens N, Gandhari M, Bleyl U, Hildenbrand R. Arens N, et al. Among authors: hildenbrand r. Int J Oncol. 2005 Jan;26(1):113-9. Int J Oncol. 2005. PMID: 15586231

4

Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue.

Hildenbrand R, Arens N. Hildenbrand R, et al. Br J Cancer. 2004 Aug 2;91(3):564-71. doi: 10.1038/sj.bjc.6601990. Br J Cancer. 2004. PMID: 15226768 Free PMC article.

5

Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.

Hildenbrand R, Schaaf A, Dorn-Beineke A, Allgayer H, Sütterlin M, Marx A, Stroebel P. Hildenbrand R, et al. Histol Histopathol. 2009 Jul;24(7):869-77. doi: 10.14670/HH-24.869. Histol Histopathol. 2009. PMID: 19475533

6

HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer.

Arens N, Bleyl U, Hildenbrand R. Arens N, et al. Among authors: hildenbrand r. Virchows Arch. 2005 May;446(5):489-96. doi: 10.1007/s00428-005-1244-0. Epub 2005 Apr 19. Virchows Arch. 2005. PMID: 15838646

7

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A. Hildenbrand R, et al. Int J Oncol. 2009 Jan;34(1):15-23. Int J Oncol. 2009. PMID: 19082473

8

[Nuclear localization of heterochromatic regions varies in hyperplastic and preneoplastic lesions of the breast].

Arens N, Stiller M, Bierbaum M, Hildenbrand R. Arens N, et al. Among authors: hildenbrand r. Verh Dtsch Ges Pathol. 2005;89:191-4. Verh Dtsch Ges Pathol. 2005. PMID: 18035690 German.

9

Phenprocoumon-induced hepatitis as an immunologically mediated drug allergic complication of antithrombotic therapy.

Dorn-Beineke A, Hassan AW, Bräutigam J, Hildenbrand R, Dempfle CE, Schwab M. Dorn-Beineke A, et al. Among authors: hildenbrand r. Thromb Haemost. 2003 Dec;90(6):1210-3. Thromb Haemost. 2003. PMID: 14652659 No abstract available.

10

The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.

Paschen A, Arens N, Sucker A, Greulich-Bode KM, Fonsatti E, Gloghini A, Striegel S, Schwinn N, Carbone A, Hildenbrand R, Cerwenka A, Maio M, Schadendorf D. Paschen A, et al. Among authors: hildenbrand r. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3297-305. doi: 10.1158/1078-0432.CCR-05-2174. Clin Cancer Res. 2006. PMID: 16740750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters